drugset / Trial / NCT04686539

Synthetic CBD as a Therapy for COVID-19

NCT04686539 ↗

Phase 1 Unknown 50 enrolled Sheba Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The study aim to test proof of concept of CBD treatment for efficacy and safety in patients suffering with mild COVID-19 infection. The CBD will be delivered via oil droplets not containing THC, compared to placebo.

Timeline

Start
2021-01-20
Primary completion
2021-11
Completion
2022-01

Drugs

EvaluationDrugModalityDoseRoute
Subject CBD Unknown — Other

Indications